| USGOV-DEPARTMENT-OF-DEFENSE |
USGOV-DEPARTMENT-OF-DEFENSE |
95%
|
USAspending awards from Department of Defense: $145,145 across 5 awards. SPE7MX25F251K 8511644365!MISCELLANEOUS; SPE7M125F2316 8511450976!MISCELLANEOUS; SPE7M125F1399 8511273757!MISCELLANEOUS | Qwen … |
| CUNY |
CUNY |
92%
|
65% of the revenues earned for the fiscal year ended September 30, 2023 was derived from the COVID-19 testing contract with CUNY that terminated during June 2023. |
| THERAPEUTIC-DNA-PRODUCTION-SERVICES-SEGMENT |
THERAPEUTIC-DNA-PRODUCTION-SERVICES-SEGMENT |
90%
|
The Company's revenues earned from sale of products and services for the three months ended March 31, 2026 was 86 % from one customer within the Therapeutic DNA Production Services segment. |
| DNA-TAGGING-AND-SECURITY-PRODUCTS-AND-SERVICES-S |
DNA-TAGGING-AND-SECURITY-PRODUCTS-AND-SERVICES-S |
85%
|
The Company's revenue earned from the sale of products and services for the six months ended March 31, 2025 was 27 % and 12 % from two customers within the DNA Tagging and Security Products and Servi… |
| THERAPEUTIC-DNA-PRODUCTION-SERVICES |
THERAPEUTIC-DNA-PRODUCTION-SERVICES |
85%
|
The Company's revenues earned from sales of products and services for the three months ended March 31, 2025 included an aggregate of 44 % and 11 % from two customers within the Therapeutic DNA Produc… |
| MDX-TESTING-SERVICES |
MDX-TESTING-SERVICES |
80%
|
The Company's revenue earned from the sale of products and services for the six months ended March 31, 2025 was 27 % and 12 % from two customers within the DNA Tagging and Security Products and Servi… |
| FLGT |
Fulgent Genetics, Inc. |
72%
|
Reciprocal relationship from FLGT graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from FLGT graph: Reciprocal relationship from BNBX graph: ices for the fiscal year ended Sept… |
| FLGT |
Fulgent Genetics, Inc. |
72%
|
ices for the fiscal year ended September 30, 2024 includes 26% and 17% from two customers within our MDx Testing Services and Therapeutic DNA Production segments, respectively. Our revenues earned fr… |
| IEHC |
IEH Corporation |
72%
|
Reciprocal relationship from IEHC graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from IEHC graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from IEHC g… |
| IEHC |
IEH Corporation |
72%
|
t our ability to maintain production of our products and achieve profitability. Unforeseen discontinuation or unavailability of certain components, such as enzymes (e.g., DNAP and RNAP), nucleotides,… |
| MRK |
Merck & Co., Inc. |
72%
|
Reciprocal relationship from MRK graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from MRK graph: Reciprocal relationship from BNBX graph: ices for the fiscal year ended Septem… |
| MRK |
Merck & Co., Inc. |
72%
|
ices for the fiscal year ended September 30, 2024 includes 26% and 17% from two customers within our MDx Testing Services and Therapeutic DNA Production segments, respectively. Our revenues earned fr… |
| MYGN |
Myriad Genetics, Inc. |
72%
|
ices for the fiscal year ended September 30, 2024 includes 26% and 17% from two customers within our MDx Testing Services and Therapeutic DNA Production segments, respectively. Our revenues earned fr… |
| MYGN |
Myriad Genetics, Inc. |
72%
|
Reciprocal relationship from MYGN graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BNBX graph: ices for the fiscal year ended Sept… |
| NVSEF |
Novartis AG |
72%
|
t our ability to maintain production of our products and achieve profitability. Unforeseen discontinuation or unavailability of certain components, such as enzymes (e.g., DNAP and RNAP), nucleotides,… |
| NVSEF |
Novartis AG |
72%
|
Reciprocal relationship from NVSEF graph: Reciprocal relationship from BNBX graph: t our ability to maintain production of our products and achieve profitability. Unforeseen discontinuation or unavai… |
| OBNB |
OBNB |
72%
|
Reciprocal relationship from OBNB graph: Reciprocal relationship from BNBX graph: Reciprocal relationship from OBNB graph: Reciprocal relationship from BNBX graph: obligations are satisfied at the po… |
| OBNB |
OBNB |
72%
|
obligations are satisfied at the point in time the Company transfers control of the goods to the customer, which in nearly all cases is when title to and risk of loss of the goods transfer to the cus… |
| BUILD-LLC |
BUILD-LLC |
62%
|
e segments. Digital Asset Treasury — Segment operations consist of managing the Company’s digital assets and implementing its DAT strategy. Therapeutic DNA Production Services — Segment operations co… |
| INTEGRATED-DNA-TECHNOLOGIES-INC |
INTEGRATED-DNA-TECHNOLOGIES-INC |
62%
|
t our ability to maintain production of our products and achieve profitability. Unforeseen discontinuation or unavailability of certain components, such as enzymes (e.g., DNAP and RNAP), nucleotides,… |
| PLC-ZIOPHARM-ONCOLOGY-INC-MAXCYTE-INC-TOUCHLIGHT |
PLC-ZIOPHARM-ONCOLOGY-INC-MAXCYTE-INC-TOUCHLIGHT |
62%
|
t our ability to maintain production of our products and achieve profitability. Unforeseen discontinuation or unavailability of certain components, such as enzymes (e.g., DNAP and RNAP), nucleotides,… |
| PRECIGEN-INC-ALDEVRON-LLC-COBRA-BIOLOGICS-LIMITE |
PRECIGEN-INC-ALDEVRON-LLC-COBRA-BIOLOGICS-LIMITE |
62%
|
t our ability to maintain production of our products and achieve profitability. Unforeseen discontinuation or unavailability of certain components, such as enzymes (e.g., DNAP and RNAP), nucleotides,… |
